GGrantIndex
← Leaderboards

Christopher M Sassetti

Univ Of Massachusetts Med Sch Worcester

$17,861,137
Attributed
$18,873,614
Total exposure
13
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.8M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$35,544,147 · 15

By mechanism

P01$29,067,826 · 10
R01$3,938,895 · 1
R21$1,366,235 · 3
UH2$1,171,191 · 1

Top collaborators

Most similar at Univ Of Massachusetts Med Sch Worcester

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis

Research focus

TuberculosisGeneticMycobacterium TuberculosisInfectionPathogenGenesPathway InteractionsProgramsStructureIn VivoComplexBaseVariantCellsPhenotypeResponseProteinsMacrophageBacteriaAnimalsGrowthPredispositionGenetic VariantLink

Grant awards (54)

Systems Genetics of Tuberculosis$2,682,482
P01 · FY2025 · AI · contact PI
Project 1 Immunometabolic Determinants of Susceptibility$760,647
P01 · FY2025 · AI · contact PI
Project 2 Bacterial determinants of host adaptation and evolutionary success$688,193
P01 · FY2025 · AI · contact PI
Core A Mouse Genetics and Genomics Core$436,889
P01 · FY2025 · AI · contact PI
Core C Admin Core$91,129
P01 · FY2025 · AI · contact PI
Systems Genetics of Tuberculosis$2,817,044
P01 · FY2024 · AI · contact PI
Project 1 Immunometabolic Determinants of Susceptibility$870,530
P01 · FY2024 · AI · contact PI
Project 2 Bacterial determinants of host adaptation and evolutionary success$585,147
P01 · FY2024 · AI · contact PI
Core A Mouse Genetics and Genomics Core$425,317
P01 · FY2024 · AI · contact PI
Core C Admin Core$134,000
P01 · FY2024 · AI · contact PI
Project 1 - Exploiting Metabolic Vulnerabilities$642,135
P01 · FY2022 · AI · contact PI
Targeted delivery of TB therapeutics$209,375
R21 · FY2022 · AI · contact PI
Systems Genetics of Tuberculosis$2,166,723
P01 · FY2021 · AI · contact PI
Project 1 - Exploiting Metabolic Vulnerabilities$647,642
P01 · FY2021 · AI · contact PI
Host Determinants of Tuberculosis Susceptibility$477,037
P01 · FY2021 · AI · contact PI
Human Genetics and Clinical Studies$424,240
P01 · FY2021 · AI · contact PI
Targeted delivery of TB therapeutics$251,250
R21 · FY2021 · AI · contact PI
A systematic method for Gain-of Function genetics in mycobacteria$244,183
R21 · FY2021 · AI · contact PI
Administrative Core$78,462
P01 · FY2021 · AI · contact PI
Systems Genetics of Tuberculosis$2,196,559
P01 · FY2020 · AI · contact PI
Project 1 - Exploiting Metabolic Vulnerabilities$650,284
P01 · FY2020 · AI · contact PI
Host Determinants of Tuberculosis Susceptibility$473,337
P01 · FY2020 · AI · contact PI
Human Genetics and Clinical Studies$430,142
P01 · FY2020 · AI · contact PI
A systematic method for Gain-of Function genetics in mycobacteria$219,183
R21 · FY2020 · AI · contact PI
Administrative Core$76,486
P01 · FY2020 · AI · contact PI
Systems Genetics of Tuberculosis$2,236,542
P01 · FY2019 · AI · contact PI
Project 1 - Exploiting Metabolic Vulnerabilities$643,722
P01 · FY2019 · AI · contact PI
Host Determinants of Tuberculosis Susceptibility$511,824
P01 · FY2019 · AI · contact PI
Human Genetics and Clinical Studies$437,721
P01 · FY2019 · AI · contact PI
Administrative Core$77,995
P01 · FY2019 · AI · contact PI
Systems Genetics of Tuberculosis$2,271,183
P01 · FY2018 · AI · contact PI
Project 1 - Exploiting Metabolic Vulnerabilities$727,143
P01 · FY2018 · AI · contact PI
Host Determinants of Tuberculosis Susceptibility$511,683
P01 · FY2018 · AI · contact PI
Human Genetics and Clinical Studies$435,888
P01 · FY2018 · AI · contact PI
Administrative Core$77,740
P01 · FY2018 · AI · contact PI
Systems Genetics of Tuberculosis$2,300,000
P01 · FY2017 · AI · contact PI
Host Determinants of Tuberculosis Susceptibility$548,164
P01 · FY2017 · AI · contact PI
Human Genetics and Clinical Studies$456,515
P01 · FY2017 · AI · contact PI
Tuberculosis Pathogenesis and Drug Response$418,750
R01 · FY2017 · AI · contact PI
Administrative Core$77,281
P01 · FY2017 · AI · contact PI
Rational Design of Combination Regimens Targeting Both Host and Pathogen$571,191
UH2 · FY2016 · AI
Tuberculosis Pathogenesis and Drug Response$418,750
R01 · FY2016 · AI · contact PI
Rational Design of Combination Regimens Targeting Both Host and Pathogen$600,000
UH2 · FY2015 · AI
Tuberculosis Pathogenesis and Drug Response$418,750
R01 · FY2015 · AI · contact PI
Tuberculosis Pathogenesis and Drug Response$418,334
R01 · FY2014 · AI · contact PI
Tuberculosis Pathogenesis and Drug Response$391,275
R01 · FY2013 · AI · contact PI
Mce transport systems of Mycobacterium tuberculosis$348,837
R01 · FY2011 · AI · contact PI
Mce transport systems of Mycobacterium tuberculosis$352,361
R01 · FY2010 · AI · contact PI
Mce transport systems of Mycobacterium tuberculosis$100,000
R01 · FY2010 · AI · contact PI
Mce transport systems of Mycobacterium tuberculosis$355,919
R01 · FY2009 · AI · contact PI
Mce transport systems of Mycobacterium tuberculosis$355,919
R01 · FY2008 · AI · contact PI
Targets for short-course TB therapy$239,119
R21 · FY2008 · AI · contact PI
Mce transport systems of Mycobacterium tuberculosis$360,000
R01 · FY2007 · AI · contact PI
Targets for short-course TB therapy$203,125
R21 · FY2007 · AI · contact PI